Cases & Deals

Auriga Partners and Kreaxi invest in Nosopharm

Clients Auriga Partners and Kreaxi

Jones Day represented Auriga Partners and Kreaxi in connection with their investment in Nosopharm, a France-based biotechnology company specialized in the research and development of new antimicrobial molecules. Alto Invest acted as co-investor in the investment round.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.